018748041

ModeX

---

August 15, 2022

Trademark Summary

The trademark ModeX was filed by ModeX Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 20, 2022, and received undefined oppositions.

Opposition Proceedings

There are undefined Oppositions claimed against trademark.

The first opposition filed on December 14, 2022 by LEK farmacevtska druzba d.d. on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and its proceedings were handled in English The second opposition filed on November 8, 2022 by MEDEX TRADE, prodaja živilskih izdelkov, d.o.o. on Likelihood of confusion. the opponent was represented by Marn, Jure and its proceedings were handled in English

The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).

Change of name and address of the trademark registration was recorded on April 21, 2024.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceuticals, therapeutic pharmaceuticals
  2. Immunopharmaceuticals
  3. Vaccines
  4. Therapeutic vaccines
  5. Antibodies
  6. Antibodies for medical purposes
  7. Multi-specific immunotherapeutic compositions for cancer and infectious diseases.
• The mark was filed in class 42 with following description of goods:
  
  1. Medical research
  2. Research and development of pharmaceuticals
  3. Research and development services in the field of antibodies, and immunotherapies for the treatment of cancer and infectious diseases
  4. Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines
  5. Pharmaceutical research and development
  6. Vaccine research and development services
  7. Research and development in the field of immunotherapy.